Viewing StudyNCT00074997



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00074997
Status: COMPLETED
Last Update Posted: 2016-06-20
First Post: 2003-12-28

Brief Title: An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 CD34 Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 HIV-1 Ribozyme OZ1 in Participants With HIV-1 Infection
Sponsor: Janssen-Cilag Pty Ltd
Organization: Janssen-Cilag Pty Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-12
Start Date Type: None
Primary Completion Date: 2008-01
Primary Completion Date Type: ACTUAL
Completion Date: 2008-01
Completion Date Type: ACTUAL
First Submit Date: 2003-12-28
First Submit QC Date: December 30 2003
Study First Post Date: 2003-12-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2013-03-15
Disp First Submit QC Date: March 15 2013
Disp First Post Date: 2013-03-21
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-06-17
Last Update Post Date: 2016-06-20
Last Update Post Date Type: ESTIMATED